VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 588 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2015. The put-call ratio across all filers is 2.30 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $980,000 | -58.8% | 4,412 | -63.2% | 1.38% | -61.6% |
| Q1 2015 | $2,381,000 | -77.1% | 11,987 | -83.5% | 3.59% | -15.3% |
| Q4 2014 | $10,376,000 | -19.2% | 72,506 | -25.9% | 4.23% | -9.8% |
| Q3 2014 | $12,834,000 | +10.7% | 97,818 | +6.4% | 4.69% | +102.0% |
| Q2 2014 | $11,598,000 | +18.2% | 91,963 | +23.5% | 2.32% | +28.3% |
| Q1 2014 | $9,813,000 | +4166.5% | 74,434 | +3695.7% | 1.81% | +3380.8% |
| Q4 2013 | $230,000 | +15.0% | 1,961 | +2.4% | 0.05% | -1.9% |
| Q3 2013 | $200,000 | -76.6% | 1,915 | -80.7% | 0.05% | -72.5% |
| Q2 2013 | $853,000 | – | 9,912 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |